KMB

Business Context and Reporting Period

Company: Kimberly-Clark Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2003
Business Overview: A global health and hygiene company operating in three segments: Personal Care (diapers, feminine care), Consumer Tissue (facial/bathroom tissue, paper towels), and Business-to-Business (health care products, professional tissue, technical papers). The company operates in over 150 countries with manufacturing facilities in 38 nations.

Key Financial Metrics (2003)

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 5.8% driven by favorable currency effects (~4%), volume growth (>2%), and acquisitions (Klabin Kimberly S.A. in Brazil and Klucze in Poland), partially offset by lower net selling prices due to intense competition.
• Profitability: Operating profit declined 2.1% despite sales growth. This was caused by higher promotional spending, increased fiber/energy/distribution costs, and a ~$140 million increase in pension expenses. These were partially offset by ~$190 million in cost savings.
• Net Income: Increased 1.2% to $1.69 billion, aided by a lower effective tax rate (23.8% vs. 29.0% in 2002) largely due to synthetic fuel tax credits ($94.1 million).
• Segment Performance:
  • Personal Care: Sales up 3.1%; Operating profit up 6.0%.
  • Consumer Tissue: Sales up 8.4%; Operating profit down 8.4% due to high fiber costs and promotion.
  • Business-to-Business: Sales up 5.8%; Operating profit up 1.9%.
• Capital Allocation: Repurchased 10.4 million shares for $529 million; increased annual dividend by 13%.

Guidance, Outlook, and Risks

2004 Outlook

• Targets: Top-line growth of 3-5%; mid-to-high single-digit bottom-line growth.
• EPS Guidance: Diluted earnings per share expected in the range of $3.55 to $3.65.
• Cost Savings: Aggressive target of $150 million in cost reductions to offset inflation in fiber, energy, and health care costs.
• Capital Spending: Expected to be approximately $750 million.
• Dividends: Planned 18% increase in 2004.

Strategic Developments

• Reorganization: Restructuring into North Atlantic Personal Care, North Atlantic Consumer Tissue, and Developing/Emerging Markets groups.
• Spin-Off Evaluation: Evaluating a potential tax-free spin-off of Neenah Paper, Technical Paper, and pulp/timber assets (expected H2 2004 if approved).

Risks and Contingencies

• Competition: Intense pricing pressure and promotional spending required to maintain market share, particularly in North American diaper and tissue categories.
• Raw Materials: Exposure to pulp and polymer resin price fluctuations. The company supplies ~40% of virgin fiber internally but intends to reduce integration, increasing commodity risk.
• Foreign Currency: Significant exposure to exchange rate fluctuations; a 10% unfavorable change could result in a $49 million pretax loss on transactional exposures.
• Pension Obligations: Defined benefit plans are underfunded by approximately $1.2 billion (PBO exceeds assets). Pension expense is expected to rise in 2004.
• Legal: Ongoing product liability lawsuits regarding latex gloves (Safeskin) and asbestos exposure claims; management believes insurance coverage is adequate.

Investor Verification Checklist

• Synthetic Fuel Partnership: Verify the sustainability of the $94.1 million tax credit benefit, which expires after 2007 and significantly lowered the 2003 effective tax rate.
• Pension Funding: Monitor the $1.2 billion underfunding gap and the impact of lower discount rates on future pension expense.
• Spin-Off Impact: Assess the financial implications of the proposed Pulp and Paper spin-off, specifically the shift from internal cost-based pulp transfers to market-based pricing.
• Margin Pressure: Track the ability to pass on raw material (pulp/resin) cost increases to consumers amidst aggressive competitor pricing.
• Acquisition Integration: Review the performance of recent acquisitions (Klabin Kimberly, Klucze) and the final purchase price allocation.